Psomagen Inc. is a leading bioscience firm committed to advanced human genomic sequencing. The corporation provides next-generation sequencing services utilized by researchers from many prestigious institutions and advanced clinical sequencing services to U.S. patients and hospitals.
Psomagen’s Next Generation Sequencing (NGS) is the future of DNA research, and the applications for this technology have the potential for enhancing individualized patient care. NGS applications include:
- Identifying rare genetic mutations and variations
- Deeper analysis of targeted DNA regions
- Advanced analysis of gene expression
- Discovery of cancer-causing genetic mutations
- Faster sequencing
Psomagen is committed to supporting students in their educational path. With this in mind, Psomagen is pleased to announce the launch of a scholarship essay contest — the Psomagen Next Generation Scholarship. The essay winner selected will be awarded $2,000 towards their studies.